Regulation of Ketone Body and Coenzyme a Metabolism in Liver

Total Page:16

File Type:pdf, Size:1020Kb

Regulation of Ketone Body and Coenzyme a Metabolism in Liver REGULATION OF KETONE BODY AND COENZYME A METABOLISM IN LIVER by SHUANG DENG Submitted in partial fulfillment of the requirements For the Degree of Doctor of Philosophy Dissertation Adviser: Henri Brunengraber, M.D., Ph.D. Department of Nutrition CASE WESTERN RESERVE UNIVERSITY August, 2011 SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of __________________ Shuang Deng ____________ _ _ candidate for the ________________________________degree Doctor of Philosophy *. (signed) ________________________________________________ Edith Lerner, PhD (chair of the committee) ________________________________________________ Henri Brunengraber, MD, PhD ________________________________________________ Colleen Croniger, PhD ________________________________________________ Paul Ernsberger, PhD ________________________________________________ Janos Kerner, PhD ________________________________________________ Michelle Puchowicz, PhD (date) _______________________June 23, 2011 *We also certify that written approval has been obtained for any proprietary material contained therein. I dedicate this work to my parents, my son and my husband TABLE OF CONTENTS Table of Contents…………………………………………………………………. iv List of Tables………………………………………………………………………. viii List of Figures……………………………………………………………………… ix Acknowledgements………………………………………………………………. xii List of Abbreviations………………………………………………………………. xiv Abstract…………………………………………………………………………….. xvii CHAPTER 1: KETONE BODY METABOLISM 1.1 Overview……………………………………………………………………….. 1 1.1.1 General introduction of ketone bodies……………………………….. 1 1.1.2 Ketogenesis is stimulated by fasting, stress and diabetes………… 1 1.1.3 Ketone body utilization in peripheral tissues………………………. 2 1.2 Adipose tissue lipolysis and regulation…………………………………….. 3 1.2.1 General introduction of lipolysis………………………………………. 3 1.2.2 Lipolysis is regulated by dietary, hormonal and neurological factors…………………………………………………………………... 3 1.2.3 Enzymes involved in lipolysis…………………………………………. 4 1.2.4 Mechanism of lipolysis…………………………………………………. 5 1.2.5 Measurement of lipolysis………………………………………………. 7 1.2.6 Adipocyte lipolysis provides substrates for ketogenesis…………… 8 1.3 Fatty acid β-oxidation and its regulation……………………………………. 9 1.3.1 Formation of acyl-CoA and its regulation……………………………. 9 1.3.2 CPT system and its regulation by malonyl- CoA, dietary and iv hormonal factors………………………………………………………... 10 1.3.3 The mitochondrial β-oxidation cycle and its regulation…………….. 12 1.3.4 Generation and utilization of acetyl-CoA…………………………….. 13 1.4 The β-hydroxy-β-methylglutaryl-CoA (HMG-CoA) cycle and its regulation.……………………………………………………………….. 1 4 1.4.1 Overview of the HMG-CoA cycle……………………………………... 14 1.4.2 Function of the mitochondria HMG-CoA…………………………….. 14 1.4.3 Regulation of the HMG-CoA cycle……………………………………. 14 1.5 C5-ketogenesis and its regulation…………………………………………… 15 1.5.1 Overview………………………………………………………………… 15 1.5.2 Sources of odd-chain fatty acids in animals…………………………. 17 1.5.3 C5-ketone body formation and its regulation………………………… 17 1.6 The ketone body utilization…………………………………………………... 18 1.6.1 The ketone body utilization pathway…………………………………. 18 1.6.2 The ketone body utilization in fetal liver…………………………….. 20 1.6.3 The ketone body utilization in peripheral tissues…………………… 21 1.7 The role of ketone bodies in mammalian metabolism…………………….. 24 1.8 The measurement of ketone body turnover………………………………... 25 1.8.1 The measurement of ketone body turnover with isotopic methods.. 25 1.8.2 Pseudoketogenesis…………………………………………………….. 27 CHAPTER 2: ANAPLEROSIS 2.1 Overview……………………………………………………………………….. 29 2.2 The cataplerosis……………………………………………………………… 29 v 2.3 The anaplerosis……………………………………………………………….. 31 2.3.1 The significance of anaplerosis……………………………………….. 31 2.3.2 Anaplerotic substrates…………………………………………………. 32 2.3.3 The measurement of anaplerosis…………………………………….. 35 2.3.4 The anaplerotic diet therapy…………………………………………... 36 CHAPTER 3: THE SYNTHESES OF ADENINE NUCLEOTIDES, COENZYME A (CoA) AND DEOXYRIBONUCLEIC ACID (DNA) IN RAT LIVER 3.1 Overview of the biosynthesis pathways of adenine nucleotides, CoA and DNA………………………………………………………………………... 38 3.1.1 Overview………………………………………………………………… 38 3.1.2 The biosynthesis pathway of adenine nucleotides………………… 38 3.1.3 The CoA biosynthesis pathway……………………………………….. 42 3.1.4 The DNA biosynthesis pathway………………………………………. 45 3.2 The techniques used for tracing the biosynthesis pathways…………….. 46 3.2.1 The techniques used for tracing ATP synthesis from ADP………… 47 3.2.2 The echniques used for tracing CoA synthesis……………………... 48 3.2.3 The techniques used for tracing DNA synthesis……………………. 48 3.3 Tracing the syntheses of biopolymers with [2H]water…………………….. 49 3.3.1 Overview………………………………………………………………… 49 3.3.2 Principle of the use of [2H]water to trace the biosyntheses of (pseudo)-biopolymers………………………………………………….. 50 3.3.3 General protocols of application of [2H]water……………………….. 53 vi 3.3.4 The pros and cons of using [2H]water………………………………... 54 3.3.5 Tracing the syntheses of biopolymers……………………………….. 56 CHAPTER 4: RESEARCH PROPOSAL 4.1 Project 1. C4- and C5-ketogenesis in rat liver……………………………… 62 4.2 Project 2. Tracing the syntheses of adenine nucleotides, CoA and DNA 65 in rat liver………………………………………………………….. 4.3 Publications…………………………………………………………………… 68 4.3.1 Deng S., Zhang G.F., Kasumov T., Roe C.R., and Brunengraber H. Interrelations between C4-ketogenesis, C5-ketogenesis, and anaplerosis In the perfused rat liver. J Biol Chem 284:27799- 27807,2009. …………………………………………………………………………… 68 4.3.2 Deng S., Zhang G.F., Kombu R.S. Harris S.R. DeSantis D., Vasquez E.J., Puchowicz M.A., Anderson V.E., Brunengraber H. Tracing the syntheses of adenine nucleotides, CoA and DNA in rat liver. To be submitted to J Biol Chem. …………………………………………………………………………… 105 CHAPTER 5: IMPLICATIONS AND FUTURE DIRECTIONS 5.1 C4-and C5-ketogenesis in rat liver…………………………………………... 146 5.1.1 Results and Discussion………………………………………………. 146 5.1.2 Future directions……………………………………………………….. 148 5.2 Tracing the syntheses of adenine nucleotides, CoA and DNA in rat liver …………………………………………………………………………... 1 50 5.2.1 Discussion and conclusions…………………………………………... 150 5.2.2 Future directions……………………………………………………….. 152 LITERATURE CITED…………………………………………………………….. 154 vii LIST OF TABLES Table 4.1. Apparent kinetics of the labeling of CoA and its components from 2H-enriched body water in rats over 10 and 31 days………. 129 viii LIST OF FIGURES Figure 1.1. Mechanism of adipocyte lipolysis regulation mediated by PKA… 6 Figure 1.2. Formation of ketone bodies from fatty acid partial β-oxidation…. 16 Figure 1.3. Pathway of ketone-body utilization in peripheral tissues………… 19 Figure 1.4. Pseudoketogensis in extrahepatic tissues………………………… 28 Figure 2.1. Main anaplerotic processes feeding into citric acid cycle……….. 30 Figure 3.1. Biosynthesis pathways of adenine nucleotides, CoA and DNA ………………………………………………………………………… 39 Figure 3.2. Pathway of Coenzyme A synthesis………………………………... 43 Figure 3.3. Protocol for using [2H]water to trace the rates of synthesis and degradation of biopolymers in vivo………………………………… 55 Figure 4.1. Scheme of C4-ketogenesis and C5-ketogenesis in the liver…….. 95 Figure 4.2. Comparison between the uptake of octanoate (A), heptanoate (B), or propionate (C) and the production of C4-ketone bodies and C5-ketone bodies………………………………………………… 96 Figure 4.3. Competition between octanoate and heptanoate for uptake by perfused rat livers……………………………………………………. 97 Figure 4.4. Competition between C4-ketogenesis from octanoate and C5- ketogenesis from heptanoate in perfused rat livers……………… 98 Figure 4.5. Profiles of concentrations of octanoate (●) and propionate (▲) in the effluent perfusate……………………………………………… 99 Figure 4.6. Labeling pattern of effluent β-hydroxybutyrate (BHB) and tissue acetyl-CoA from livers perfused with increasing concentrations ix 13 13 of [1- C]octanoate (A) or [8- C]octanoate (B)………………….. 100 Figure 4.7 Sharing of acetyl groups between C4- and C5-ketogenesis reflected by the mass isotopomer distribution of BHB and BHP… 101 Figure 4.8 Mass isotopomer distribution of HMG-CoA (A) and HEG-CoA (B) in livers perfused with constant 1 mM [1-13C]heptanoate and increasing concentrations of unlabeled octanoate……………….. 102 Figure 4.9 Mass isotopomer distribution of BHB-CoA and AcAc-CoA in livers perfused with increasing concentrations of [1-13C]octanoate …………………………………………………………………………. 103 Figure 4.10 Anaplerosis and glucose labeling from increasing 13 13 concentrations of [ C3]propionate (♦) or [5,6,7- C3]heptanoate (■,▲)…………………………………………………………………. 104 Figure 4.11. Sites of labeling of nucleotides, CoA and DNA from [2H]water ………………………………………………………………………... 132 Figure 4.12. In vivo labeling of liver CoA from [2H]water over 31 days……… 133 Figure 4.13. In vivo labeling of liver dR-DNA [2H] from water over 10 days… 134 Figure 4.14. Mass isotopomer distribution of liver perfusate glucose in 2 100% H2O buffer…………………………………………………... 135 Figure 4.15. Mass isotopomer distribution of glucose-6-P, ribose-5-P and PEP in livers perfused with 4 mM unlabeled glucose in 100% 2 H2O buffer………………………………………………………….. 136 Figure 4.16. M1 enrichment of AMP, ADP, ATP and CoA in livers perfused 2 with 4 mM unlabeled glucose in 100% H2O buffer……………… 137 x Figure 4.17. M1 enrichment of AMP, ADP, ATP in livers perfused with 4 mM unlabeled glucose in buffers enriched 0 to 100% with 2 H2O…………………………………………………………………... 138 Figure 4.18. M1 enrichment of CoA and its components in livers perfused with 4 mM unlabeled glucose in buffers enriched 0 to
Recommended publications
  • Effects of Glucagon, Glycerol, and Glucagon Plus Glycerol On
    Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2011 Effects of glucagon, glycerol, and glucagon plus glycerol on gluconeogenesis, lipogenesis, and lipolysis in periparturient Holstein cows Nimer Mehyar Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Biochemistry, Biophysics, and Structural Biology Commons Recommended Citation Mehyar, Nimer, "Effects of glucagon, glycerol, and glucagon plus glycerol on gluconeogenesis, lipogenesis, and lipolysis in periparturient Holstein cows" (2011). Graduate Theses and Dissertations. 11923. https://lib.dr.iastate.edu/etd/11923 This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Effects of glucagon, glycerol, and glucagon plus glycerol on gluconeogenesis, lipogenesis, and lipolysis in periparturient Holstein cows by Nimer Mehyar A thesis submitted to graduate faculty in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE Major: Biochemistry Program of Study Committee: Donald C. Beitz, Major Professor Ted W. Huiatt Kenneth J. Koehler Iowa State University Ames, Iowa 2011 Copyright Nimer Mehyar, 2011. All rights reserved ii To My Mother To Ghada Ali, Sarah, and Hassan
    [Show full text]
  • THE AEROBIC (Air-Robic!) PATHWAYS
    THE AEROBIC (air-robic!) PATHWAYS Watch this video on aerobic glycolysis: http://ow.ly/G5djv Watch this video on oxygen use: http://ow.ly/G5dmh Energy System 1 – The Aerobic Use of Glucose (Glycolysis) This energy system involves the breakdown of glucose (carbohydrate) to release energy in the presence of oxygen. The key to this energy system is that it uses OXYGEN to supply energy. Just like the anaerobic systems, there are many negatives and positives from using this pathway. Diagram 33 below summarises the key features of this energy system. When reading the details on the table keep in mind the differences between this and the previous systems that were looked at. In this way a perspective of their features can be appreciated and applied. Diagram 33: The Key Features of the Aerobic Glycolytic System Highlight 3 key features in the diagram that are important to the functioning of this system. 1: ------------------------------------------------------------------------------------------------------------------------------------------------------- 2: ------------------------------------------------------------------------------------------------------------------------------------------------------- 3: ------------------------------------------------------------------------------------------------------------------------------------------------------- Notes ---------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------
    [Show full text]
  • Corticosteroid Treatment, Serum Lipids and Coronary Artery Disease D. B. JEFFERYS M
    Postgrad Med J: first published as 10.1136/pgmj.56.657.491 on 1 July 1980. Downloaded from Postgraduate Medical Journal (July 1980) 56, 491-493 Corticosteroid treatment, serum lipids and coronary artery disease D. B. JEFFERYS M. H. LESSOF B.Sc., M.R.C.P. M.D., F.R.C.P. M. B. MATTOCK Ph.D. Department of Medicine, Guy's Hospital, London Bridge SE] 9RT Summary cholesterol out of the tissue and back into the general Serum lipids and the cholesterol concentrations in the metabolic pool, where it may be catabolized. high density lipoprotein (HDL) fractions were meas- In this study the authors have looked at the long- ured in patients receiving long-term corticosteroid term effects of corticosteroids on HDL cholesterol. treatment for connective tissue disorders and asthma. They have studied 3 groups: patients who are receiv- Patients who were not receiving corticosteroid ing corticosteroids; age-, sex- and disease-matched treatment had blood lipid levels which did not differ patients who are not receiving such treatment; and from those of healthy people. However, female (but healthy age- and sex-matched controls. not male) patients who had received prednisolone for a mean period of 3-1 years had a significant elevation Patients and methods in total cholesterol and a large decrease in HDL Subjects cholesterol. It seems possible that high levels of The serum total cholesterol, triglycerides and copyright. corticosteroids may increase the incidence of pre- HDL cholesterol were measured for 16 pre-meno- menopausal ischaemic heart disease in females. pausal female patients (age range 18-34 years) and 15 males (ages 24-38 years) who were all receiving Introduction long-term corticosteroid treatment.
    [Show full text]
  • Adipocyte Glucocorticoid Receptor Is Important in Lipolysis and Insulin Resistance Due to Exogenous Steroids, but Not Insulin Resistance Caused by High Fat Feeding
    Adipocyte glucocorticoid receptor is important in lipolysis and insulin resistance due to exogenous steroids, but not insulin resistance caused by high fat feeding The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Shen, Yachen, Hyun Cheol Roh, Manju Kumari, and Evan D. Rosen. 2017. “Adipocyte glucocorticoid receptor is important in lipolysis and insulin resistance due to exogenous steroids, but not insulin resistance caused by high fat feeding.” Molecular Metabolism 6 (10): 1150-1160. doi:10.1016/j.molmet.2017.06.013. http:// dx.doi.org/10.1016/j.molmet.2017.06.013. Published Version doi:10.1016/j.molmet.2017.06.013 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:34492181 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Original Article Adipocyte glucocorticoid receptor is important in lipolysis and insulin resistance due to exogenous steroids, but not insulin resistance caused by high fat feeding Yachen Shen 1,4,5, Hyun Cheol Roh 1,5, Manju Kumari 1, Evan D. Rosen 1,2,3,* ABSTRACT Objective: The critical role of adipose tissue in energy and nutrient homeostasis is influenced by many external factors, including overnutrition, inflammation, and exogenous hormones. Prior studies have suggested that glucocorticoids (GCs) in particular are major drivers of physiological and pathophysiological changes in adipocytes. In order to determine whether these effects directly require the glucocorticoid receptor (GR) within adipocytes, we generated adipocyte-specific GR knockout (AGRKO) mice.
    [Show full text]
  • Hydroxy–Methyl Butyrate (HMB) As an Epigenetic Regulator in Muscle
    H OH metabolites OH Communication The Leucine Catabolite and Dietary Supplement β-Hydroxy-β-Methyl Butyrate (HMB) as an Epigenetic Regulator in Muscle Progenitor Cells Virve Cavallucci 1,2,* and Giovambattista Pani 1,2,* 1 Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Roma, Italy 2 Institute of General Pathology, Università Cattolica del Sacro Cuore, 00168 Roma, Italy * Correspondence: [email protected] (V.C.); [email protected] (G.P.) Abstract: β-Hydroxy-β-Methyl Butyrate (HMB) is a natural catabolite of leucine deemed to play a role in amino acid signaling and the maintenance of lean muscle mass. Accordingly, HMB is used as a dietary supplement by sportsmen and has shown some clinical effectiveness in preventing muscle wasting in cancer and chronic lung disease, as well as in age-dependent sarcopenia. However, the molecular cascades underlying these beneficial effects are largely unknown. HMB bears a significant structural similarity with Butyrate and β-Hydroxybutyrate (βHB), two compounds recognized for important epigenetic and histone-marking activities in multiple cell types including muscle cells. We asked whether similar chromatin-modifying actions could be assigned to HMB as well. Exposure of murine C2C12 myoblasts to millimolar concentrations of HMB led to an increase in global histone acetylation, as monitored by anti-acetylated lysine immunoblotting, while preventing myotube differentiation. In these effects, HMB resembled, although with less potency, the histone Citation: Cavallucci, V.; Pani, G. deacetylase (HDAC) inhibitor Sodium Butyrate. However, initial studies did not confirm a direct The Leucine Catabolite and Dietary inhibitory effect of HMB on HDACs in vitro. β-Hydroxybutyrate, a ketone body produced by the Supplement β-Hydroxy-β-Methyl liver during starvation or intense exercise, has a modest effect on histone acetylation of C2C12 Butyrate (HMB) as an Epigenetic Regulator in Muscle Progenitor Cells.
    [Show full text]
  • Fatty Acid Biosynthesis
    BI/CH 422/622 ANABOLISM OUTLINE: Photosynthesis Carbon Assimilation – Calvin Cycle Carbohydrate Biosynthesis in Animals Gluconeogenesis Glycogen Synthesis Pentose-Phosphate Pathway Regulation of Carbohydrate Metabolism Anaplerotic reactions Biosynthesis of Fatty Acids and Lipids Fatty Acids contrasts Diversification of fatty acids location & transport Eicosanoids Synthesis Prostaglandins and Thromboxane acetyl-CoA carboxylase Triacylglycerides fatty acid synthase ACP priming Membrane lipids 4 steps Glycerophospholipids Control of fatty acid metabolism Sphingolipids Isoprene lipids: Cholesterol ANABOLISM II: Biosynthesis of Fatty Acids & Lipids 1 ANABOLISM II: Biosynthesis of Fatty Acids & Lipids 1. Biosynthesis of fatty acids 2. Regulation of fatty acid degradation and synthesis 3. Assembly of fatty acids into triacylglycerol and phospholipids 4. Metabolism of isoprenes a. Ketone bodies and Isoprene biosynthesis b. Isoprene polymerization i. Cholesterol ii. Steroids & other molecules iii. Regulation iv. Role of cholesterol in human disease ANABOLISM II: Biosynthesis of Fatty Acids & Lipids Lipid Fat Biosynthesis Catabolism Fatty Acid Fatty Acid Degradation Synthesis Ketone body Isoprene Utilization Biosynthesis 2 Catabolism Fatty Acid Biosynthesis Anabolism • Contrast with Sugars – Lipids have have hydro-carbons not carbo-hydrates – more reduced=more energy – Long-term storage vs short-term storage – Lipids are essential for structure in ALL organisms: membrane phospholipids • Catabolism of fatty acids –produces acetyl-CoA –produces reducing
    [Show full text]
  • Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses
    life Review Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses Inseok Choi , Hyewon Son and Jea-Hyun Baek * School of Life Science, Handong Global University, Pohang, Gyeongbuk 37554, Korea; [email protected] (I.C.); [email protected] (H.S.) * Correspondence: [email protected]; Tel.: +82-54-260-1347 Abstract: The tricarboxylic acid cycle (TCA) is a series of chemical reactions used in aerobic organisms to generate energy via the oxidation of acetylcoenzyme A (CoA) derived from carbohydrates, fatty acids and proteins. In the eukaryotic system, the TCA cycle occurs completely in mitochondria, while the intermediates of the TCA cycle are retained inside mitochondria due to their polarity and hydrophilicity. Under cell stress conditions, mitochondria can become disrupted and release their contents, which act as danger signals in the cytosol. Of note, the TCA cycle intermediates may also leak from dysfunctioning mitochondria and regulate cellular processes. Increasing evidence shows that the metabolites of the TCA cycle are substantially involved in the regulation of immune responses. In this review, we aimed to provide a comprehensive systematic overview of the molecular mechanisms of each TCA cycle intermediate that may play key roles in regulating cellular immunity in cell stress and discuss its implication for immune activation and suppression. Keywords: Krebs cycle; tricarboxylic acid cycle; cellular immunity; immunometabolism 1. Introduction The tricarboxylic acid cycle (TCA, also known as the Krebs cycle or the citric acid Citation: Choi, I.; Son, H.; Baek, J.-H. Tricarboxylic Acid (TCA) Cycle cycle) is a series of chemical reactions used in aerobic organisms (pro- and eukaryotes) to Intermediates: Regulators of Immune generate energy via the oxidation of acetyl-coenzyme A (CoA) derived from carbohydrates, Responses.
    [Show full text]
  • There Are Three Major Biological Molecules Classified As Ketone Bodies
    There are three major biological molecules classified as ketone bodies: These ketone bodies are water soluble and do not need specific transporters to cross membranes. Synthesis of acetoacetate 1. React two acetyl-CoA molecules with each other using thiolase. This is called acetoacetyl-CoA. What is the second product? 2. React a third acetyl-CoA molecule with acetoacetyl-CoA. This step is catalyzed by hydroxymethylglutaryl-CoA synthase (HMG-CoA synthase). a. Deprotonate C2 of acetyl-CoA. You have created a great nucleophile. b. React your newly formed carbanion nucleophile with the electrophilic carbonyl C3 of acetoacetyl-CoA. c. Protonate the oxyanion. d. Use water as a nucleophile to react with the electrophilic carbonyl of the thioester of the newly added acetyl-CoA unit. This results in a carboxylate functional group. e. Your product should contain a 5-carbon chain, which starts with a thioester to CoA, ends with a carboxylate, and has a hydroxyl and a methyl group attached to C3. This is β-hydroxy-β- methylglutaryl-CoA (HMG-CoA). 3. An acetyl-CoA group is eliminated. This step is catalyzed by hydroxymethylglutaryl-CoA lyase (HMG- CoA lyase). a. A base deprotonates the hydroxyl group of β-hydroxy-β-methylglutaryl-CoA. b. A pair of electrons from the oxyanion moves to form a carbonyl. C2 leaves as a carbanion [which delocalizes into the adjacent thioester carbonyl]. c. The first product is acetoacetate. d. The carbanion picks up the proton and leaves as acetyl-CoA. Formation of acetone from acetoacetate This occurs in a non-enzymatic fashion because of the arrangement of the ketone in the β position from the carboxylate in acetoacetate and causes problems since acetone builds up.
    [Show full text]
  • Glycolysis and Glyceroneogenesis In
    GLYCOLYSIS AND GLYCERONEOGENESIS IN ADIPOCYTES: EFFECTS OF ROSIGLITAZONE, AN ANTI-DIABETIC DRUG By SOREIYU UMEZU Bachelor of Science in Biochemistry and Molecular Biology Oklahoma State University Stillwater, OK 2005 Submitted to the Faculty of the Graduate College of the Oklahoma State University in partial fulfillment of the requirements for the Degree of DOCTOR OF PHILOSOPHY July, 2010 GLYCOLYSIS AND GLYCERONEOGENESIS IN ADIPOCYTES: EFFECTS OF ROSIGLITAZONE, AN ANTI-DIABETIC DRUG Dissertation Approved: Dr. Jose L Soulages Dissertation Adviser Dr. Chang-An Yu Dr. Andrew Mort Dr. Jack Dillwith Dr. A. Gordon Emslie Dean of the Graduate College ii ACKNOWLEDGMENTS First, I would like to immensely thank my advisor, Dr. Jose Soulages, for his support and guidance throughout my graduate studies. Without Dr. Soulages extensive expertise and knowledge along with his sense of humor I would not have achieved my goal of obtaining my Doctorate in Biochemistry. I would also like to thank Dr. Estela Arrese for her kind and generous advice. Both Dr. Soulages and Dr. Arrese have made a tremendous impact on me personally and professionally. I would like to thank all the members of my committee: Dr. Chang-An Yu, Dr. Andrew Mort, and Dr. Jack Dillwith who have devoted their time reading my dissertation and their patience for my procrastination. Their support and guidance has been invaluable and extremely appreciative. Most importantly, I want to acknowledge my parents: (Dr.) Mrs. Fumie Umezu and (Dr.) Mr. Yasuiki Umezu, for their unwavering support of me throughout my time in the U.S. and for suffering me while I’m doing whatever I want in my life.
    [Show full text]
  • Fatty Acid Synthesis ANSC/NUTR 618 Lipids & Lipid Metabolism Fatty Acid Synthesis I
    Handout 5 Fatty Acid Synthesis ANSC/NUTR 618 Lipids & Lipid Metabolism Fatty Acid Synthesis I. Overall concepts A. Definitions 1. De novo synthesis = synthesis from non-fatty acid precursors a. Carbohydrate precursors (glucose and lactate) 1) De novo fatty acid synthesis uses glucose absorbed from the diet rather than glucose synthesized by the liver. 2) De novo fatty acid synthesis uses lactate derived primarily from glucose metabolism in muscle and red blood cells. b. Amino acid precursors (e.g., alanine, branched-chain amino acids) 1) De novo fatty acid synthesis from amino acids is especially important during times of excess protein intake. 2) Use of amino acids for fatty acid synthesis may result in nitrogen overload (e.g., the Atkins diet). c. Short-chain organic acids (e.g., acetate, butyrate, and propionate) 1) The rumen of ruminants is a major site of short-chain fatty acid synthesis. 2) Only small amounts of acetate circulate in non-ruminants. 2. Lipogenesis = fatty acid or triacylglycerol synthesis a. From preformed fatty acids (from diet or de novo fatty acid synthesis) b. Requires source of carbon (from glucose or lactate) for glycerol backbone 3T3-L1 Preadipocytes at confluence. No lipid 3T3-L1 Adipocytes after 6 days of filling has yet occurred. differentiation. Dark spots are lipid droplets. 1 Handout 5 Fatty Acid Synthesis B. Tissue sites of de novo fatty acid biosynthesis 1. Liver. In birds, fish, humans, and rodents (approx. 50% of fatty acid biosynthesis). 2. Adipose tissue. All livestock species synthesize fatty acids in adipose tissue; rodents synthesize about 50% of their fatty acids in adipose tissue.
    [Show full text]
  • Beta (Β)-Oxidation of Fatty Acid and Its Associated Disorders
    Vol. 5 (1), pp. 158-172, December, 2018 ©Global Science Research Journals International Journal of Clinical Biochemistry Author(s) retain the copyright of this article. http://www.globalscienceresearchjournals.org/ Review Article Beta (β)-Oxidation of Fatty Acid and its associated Disorders Satyam Prakash Assistant Professor, Dept. of Biochemistry, Janaki Medical College Teaching Hospital, Janakpur, Nepal Mobile: +977-9841603704, E-mail: [email protected] Accepted 18 December, 2018 The lipids of metabolic significance in the mammalian organisms include triacylglycerols, phospholipids and steroids, together with products of their metabolism such as long-chain fatty acids, glycerol and ketone bodies. The fatty acids which are present in the triacylglycerols in the reduced form are the most abundant source of energy and provide energy twice as much as carbohydrates and proteins. Fatty acids represent an important source of energy in periods of catabolic stress related to increased muscular activity, fasting or febrile illness, where as much as 80% of the energy for the heart, skeletal muscles and liver could be derived from them. The prime pathway for the degradation of fatty acids is mitochondrial fatty acid β-oxidation (FAO). The relationship of fat oxidation with the utilization of carbohydrate as a source of energy is complex and depends upon tissue, nutritional state, exercise, development and a variety of other influences such as infection and other pathological states. Inherited defects for most of the FAO enzymes have been identified and characterized in early infancy as acute life-threatening episodes of hypoketotic, hypoglycemic coma induced by fasting or febrile illness. Therefore, this review briefly highlights mitochondrial β-oxidation of fatty acids and associated disorders with clinical manifestations.
    [Show full text]
  • Two-Week Exclusive Supplementation of Modified Ketogenic Nutrition Drink Reserves Lean Body Mass and Improves Blood Lipid Profile in Obese Adults: a Randomized Clinical Trial
    nutrients Article Two-Week Exclusive Supplementation of Modified Ketogenic Nutrition Drink Reserves Lean Body Mass and Improves Blood Lipid Profile in Obese Adults: A Randomized Clinical Trial Hae-Ryeon Choi 1 , Jinmin Kim 2, Hyojung Lim 3 and Yoo Kyoung Park 1,* 1 Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Yongin, Gyeonggi-do 17104, Korea; [email protected] 2 Nutritional Product R&D team, Maeil Innovation Center, Maeil Dairies Co., Ltd., Pyeongtaek, Gyeonggi-do 17714, Korea; [email protected] 3 MDwell Inc., Seoul 06170, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-10-6231-1931 Received: 6 October 2018; Accepted: 21 November 2018; Published: 3 December 2018 Abstract: The ketogenic diet has long been recommended in patients with neurological disorders, and its protective effects on the cardiovascular system are of growing research interest. This study aimed to investigate the effects of two-week of low-calorie ketogenic nutrition drinks in obese adults. Subjects were randomized to consume drinks either a ketone-to-non-ketone ratio of 4:1 (KD 4:1), a drink partially complemented with protein at 1.7:1 (KD 1.7:1), or a balanced nutrition drink (BD). Changes in body weight, body composition, blood lipid profile, and blood ketone bodies were investigated. Blood ketone bodies were induced and maintained in the group that consumed both 4:1 and 1.7:1 ketogenic drinks (p < 0.001). Body weight and body fat mass significantly declined in all groups between 0 and 1 week and between 1 and 2 weeks (p < 0.05), while skeletal muscle mass remained unchanged only in the KD 1.7:1 group (p > 0.05).
    [Show full text]